Legal Representation
Attorney
James W. Repass
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 4, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Mar 4, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 1, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 6, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 6, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 17, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 4, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 1, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 1, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 1, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 1, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 14, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 14, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 14, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 14, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 14, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 14, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 11, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 12, 2022 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Apr 11, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 9, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
COVID-19 vaccine preparations
Class 025
T-shirts, shirts, hats, baseball caps
Class 042
COVID-19 vaccine research and development; providing information about medical and scientific research in the field of vaccine development and the prevention and treatment of COVID-19
Additional Information
Design Mark
The mark consists of the words "THE WORLD'S COVID-19 VACCINE" written above the words "TEXAS CHILDREN'S HOSPITAL." "COVID-19" is in red letters. The "I" in COVID is an image of a syringe. A design in red comprised of a solid circle centered above three upwardly angled or curved lines of increasing length is adjacent to "TEXAS CHILDREN'S HOSPITAL". The rest of the lettering is in black. The white in the drawing is background areas only and not claimed as a feature of the mark.
Color Claim
The color(s) red and black is/are claimed as a feature of the mark.
Pseudo Mark
THE WORLD'S COVID ONE NINE VACCINE TEXAS CHILDREN'S HOSPITAL, THE WORLD'S COVID NINETEEN VACCINE TEXAS CHILDREN'S HOSPITAL
Other
as to TEXAS CHILDREN'S HOSPITAL
Classification
International Classes
005
025
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THE WORLD'S COVID-19 VACCINE" FOR INTERNATIONAL CLASSES 005 AND 044 AND "THE WORLD'S COVID-19 VACCINE TEXAS CHILDREN'S HOSPITAL" FOR INTERNATIONAL CLASS 025 APART FROM THE MARK AS SHOWN.